Janine Jamieson

Janine Jamieson is European Editor - with special interest in Drug/Device Combination Products, International Pharmaceutical Quality. She shares the global regulatory dialogue around CMC/GMP challenges for biopharma, advanced therapies and combination products.

  • drug device combos
    Meeting Report

    MD5: Innovation in Drug-Device Combinations

    2021-11-23T14:30:00

    The session was opened by Bjorg Hunter posing a question about how innovative companies can manage often complex and different global regulations when they are developing connected, environmentally friendly products for the benefit of the patients…

  • eu
    Meeting Report

    IVD3: EU Implementation: Current State

    2021-11-23T14:30:00

    The session was opened by Bjorg Hunter posing a question about how innovative companies can manage often complex and different global regulations when they are developing connected, environmentally friendly products for the benefit of the patients…